Humana (HUM)
(Delayed Data from NYSE)
$279.45 USD
-37.29 (-11.77%)
Updated Oct 1, 2024 04:00 PM ET
After-Market: $278.50 -0.95 (-0.34%) 7:58 PM ET
3-Hold of 5 3
B Value F Growth F Momentum D VGM
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$279.45 USD
-37.29 (-11.77%)
Updated Oct 1, 2024 04:00 PM ET
After-Market: $278.50 -0.95 (-0.34%) 7:58 PM ET
3-Hold of 5 3
B Value F Growth F Momentum D VGM
Zacks News
Will Trump Era Mean Disaster for Health Insurers?
by Mark Vickery
Health insurance companies provided a major overhaul of their business plans to comply with Obamacare, and now they look to be put on a new road forward.
WellCare Health Plans (WCG) and Unit Receive Rating Action
by Zacks Equity Research
WellCare Health Plans, Inc. (WCG) recently received rating action from credit rating giant, Moody's Investors Service, a wing of Moody's Corp. (MCO).
UnitedHealth & CVS Pharmacy Partner to Improve Healthcare
by Zacks Equity Research
In keeping with the intention to provide convenient and low healthcare option to customers, UnitedHealth Group Inc.'s (UNH) pharmacy care services business - OptumRx - recently joined forces with CVS Pharmacy
Zacks.com featured highlights: Edgewell Personal Care, Cambrex, Humana, Research Frontiers and Galena Biopharma
by Zacks Equity Research
Zacks.com featured highlights: Edgewell Personal Care, Cambrex, Humana, Research Frontiers and Galena Biopharma
Humana Partners DaVita Unit to Enhance MA Plans in Florida
by Zacks Equity Research
Humana Inc. (HUM) recently joined forces with JSA Medical Group to add one primary care practice to its Florida Medicare Advantage (MA) Plan Networks.
Health Insurers Face Regulatory Scrutiny, Exchange Issues
by Zacks Equity Research
Legislation has undoubtedly altered the regulatory landscape in ways that are not always beneficial to a private health insurer's bottom line.
New Strong Buy Stocks for September 2nd
by Indradip Ghosh
Here are 5 stocks added to the Zacks Rank #1 (Strong Buy) List for Friday
New Strong Buy Stocks for July 26th
by Zacks Equity Research
Here are 5 stocks added to the Zacks Rank #1 (Strong Buy) List for Tuesday
Health Insurers Suffer on High Costs, Unprofitable Exchanges
by Zacks Equity Research
A fragile global economy presents a headwind for insurers looking to expand their international operations.
Stock Market News for June 03, 2016
by Zacks Equity Research
Benchmarks finished in the green on Thursday following encouraging U.S. private sector jobs data and gains in healthcare stocks
U.S. Health Insurers Provide Defense Amid Volatility
by Zacks Equity Research
The population of Medicare beneficiaries will grow by 36% by the end of this decade, led by a vast aging baby boomer population.
Health Insurance Stock Outlook - Feb. 2016
by Zacks Equity Research
The ACA law has been in place for almost six years now, and has mostly been absorbed by the industry.
Will Election 2016 Mean New Challenges for Health Insurers?
by Zacks Equity Research
Presidential candidates are looking at ways to fine tune the provisions of the healthcare legislation, which, if implemented, will see insurers reworking their business strategies.
Health Insurers Gain Under Obamacare
by Zacks Equity Research
Pressure on profit margins in the U.S. market has compelled American health insurers to look to foreign markets for sustained growth and profitability.
Health Insurance Stock Outlook - Oct. 2015
by Zacks Equity Research
Health insurance plans face both challenges and opportunities, many of which require a shift in business mix.
Health Insurance Stock Outlook - Oct. 2015
by Zacks Equity Research
Health insurance plans face both challenges and opportunities, many of which require a shift in business mix.
HMOs Burn Hot This Summer
by Abhijit Ghosh
This 13-company industry is currently ranked #16 out of 265 industries of Zacks ranks (top 6%). You can't do better than that when there are this many companies inside a given industry.
HMOs Burn Hot This Summer
by John Blank
This 13-company industry is currently ranked #16 out of 265 industries of Zacks ranks (top 6%). You can't do better than that when there are this many companies inside a given industry.
Health Insurers Walk Tightrope with ACA Challenges
by Zacks Equity Research
Players in the U.S. health insurance industry are expected to suffer from narrowed operating margins for the next few years.
Health Insurers Shine in Obamacare Era
by Zacks Equity Research
Carriers in the health insurance sector are in a race to win Medicare Advantage market share and the fastest way of achieving the target by acquiring a company in the same business.
Health Insurance Stock Outlook - June 2015
by Abhijit Ghosh
Although previously feared by the insurers, the changes and challenges put forth by the health care reform act haven't really caused damage to them.
Health Insurance Stock Outlook - June 2015
by Zacks Equity Research
Although previously feared by the insurers, the changes and challenges put forth by the health care reform act haven't really caused damage to them.
Health Insurers Continue to Face ACA Challenges
by Zacks Equity Research
The biggest uncertainty now is that subsidies made available by the Affordable Care Act (ACA) have been challenged in the Supreme Court.
Health Insurers Find ObamaCare Headwinds Easing
by Zacks Equity Research
Insurers are eying growth and expansion opportunities accompanying the critical challenges of modernizing the health care system.
Health Insurance Stock Outlook - Feb. 2015
by Zacks Equity Research
Fears of adverse selection, premium increases, and stratospheric managed care medical loss ratios abated and the players started refocusing on long-term growth opportunities.